Outcome of Board Meeting of the Company held on Monday, May 12, 2025 for Conversion of 4,08,333 warrants into 4,08,333 equity shares of face value of Rs. 10/- each.

pdf

Trident Texofab Ltd.

12 May 2025

250.00

0.81%

Corp. Note

Trident Texofab Ltd - 540726 - Board Meeting Outcome for Outcome Of Board Meeting Of The …

BSE India

Conversion of 4,08,333 warrants into 4,08,333 equity shares of face value of Rs. 10/- each.

pdf

Trident Texofab Ltd.

29 Apr 2025

250.00

0.81%

Corp. Note

Trident Texofab Ltd - 540726 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyTrident Texofab Ltd 2CIN NO.L17120GJ2008PLC054976 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY B+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: RAHUL JARIWALA Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: cs@tridenttexofab.com Name of the Chief Financial Officer: JENISH B JARIWALA Designation: CHIEF FINANCIAL OFFICER EmailId: cfo@tridenttexofab.com Date: 29/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Trident Texofab Ltd.

11 Apr 2025

250.00

0.81%

Company Update

Trident Texofab Ltd - 540726 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as received from KFin Technologies Limited- Company''s Registrar and Share Transfer Agent for the quarter ended March 31, 2025.

pdf

Trident Texofab Ltd.

01 Apr 2025

250.00

0.81%

SAST

Trident Texofab Ltd - 540726 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Trident Lifeline Ltd

pdf

Trident Texofab Ltd.

31 Mar 2025, 01:01PM

250.00

0.81%

SAST

Trident Texofab Ltd - 540726 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from 01st April, 2025 and shall be opened 48 (Forty-Eight) hours after the conclusion of the Meeting of the Board of Directors to be held for the purpose of declaration of Audited Standalone Financial Results for the Quarter and Year ended March 31, 2025.

pdf

Trident Texofab Ltd.

29 Mar 2025

250.00

0.81%

Company Update

Trident Texofab Ltd - 540726 - Disclosure Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares …

BSE India

In compliance with Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, please find enclosed herewith disclosure received from Trident Lifeline Limited in terms of sub regulation (1) of said regulation.

pdf

Trident Texofab Ltd.

26 Mar 2025

250.00

0.81%

Corp. Note

Trident Texofab Ltd - 540726 - Board Meeting Outcome for Separate Meeting Of Independent Directors

BSE India

Outcome of The Separate Meeting Of Independent Directors Of The Company Held On Wednesday, March 26, 2025.

pdf

Trident Texofab Ltd.

22 Mar 2025

250.00

0.81%

Company Update

Trident Texofab Ltd - 540726 - Clarification Letter - Correction Of Typographical Error In Board Meeting …

BSE India

This is to inform you that we are hereby rectified the inadvertent clerical/typographical error in the Annexure A Disclosure under Outcome of Board Meeting of the Company held on March 17, 2025 for Conversion of 17,04,661 warrants into 17,04,661 equity shares of face value of Rs. 10/- each

pdf

Is Trident Texofab Ltd. worth buying?

42 Votes:

Buy 64.29%

Sell 19.05%

Hold 16.67%